LOTEMAX GEL
LOTEMAX GEL
Approved
DIN Number
02435853
Drug Class
Human
Market Date
Jun 25, 2015
Company
HC
bausch & lomb inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02435853
AIG Number0152508002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
S01BA14 LOTEPREDNOL
Product Specifications
Dosage FormGel
Route of AdministrationOphthalmic
AHFS Classification52:08.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
LOTEPREDNOL ETABONATEActive
Strength: 0.5 % / W/W
Monograph: LOTEPREDNOL ETABONATE